ARF functions as a melanoma tumor suppressor by inducing p53-independent senescence, Proc Natl Acad Sci U S A, vol.104, pp.10968-10973, 2007. ,
Melanomagenesis: overcoming the barrier of melanocyte senescence, Cell Cycle, vol.7, pp.1944-1948, 2008. ,
p16INK4a-induced senescence is disabled by melanoma-associated mutations, Aging Cell, vol.7, pp.733-745, 2008. ,
The serial cultivation of human diploid cell strains, Exp Cell Res, vol.25, pp.585-621, 1961. ,
Downregulation of APE1/Ref-1 is involved in the senescence of mesenchymal stem cells, Stem Cells, vol.27, pp.1455-1462, 2009. ,
p53 effects both the duration of G2/M arrest and the fate of temozolomide-treated human glioblastoma cells, Cancer Res, vol.61, pp.1957-1963, 2001. ,
p53-Dependent transcriptional repression of c-myc is required for G1 cell cycle arrest, Mol Cell Biol, vol.25, pp.7423-7431, 2005. ,
Expression profiling reveals novel pathways in the transformation of melanocytes to melanomas, Cancer Res, vol.64, pp.5270-5282, 2004. ,
Expression of TBX2 promotes anchorage-independent growth and survival in the p53-negative SW13 adrenocortical carcinoma, Cancer Lett, vol.278, pp.230-240, 2009. ,
Senescence bypass screen identifies TBX2, which represses Cdkn2a (p19(ARF)) and is amplified in a subset of human breast cancers, Nat Genet, vol.26, pp.291-299, 2000. ,
An oncogenic role for ETV1 in melanoma, Cancer Res, vol.70, pp.2075-2084, 2010. ,
A CDKN2A mutation in familial melanoma that abrogates binding of p16INK4a to CDK4 but not CDK6, Cancer Res, vol.67, pp.9134-9141, 2007. ,
Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF, Cell, vol.91, pp.649-659, 1997. ,
,
Functional, structural, and genetic evaluation of 20 CDKN2A germ line mutations identified in melanoma-prone families, 2009. ,
URL : https://hal.archives-ouvertes.fr/hal-00539303
, , 2007.
, Temozolomide induces senescence but not apoptosis in human melanoma cells, Br J Cancer, vol.97, pp.1225-1233
BRAF(E600) in benign and malignant human tumours, Oncogene, vol.27, pp.877-895, 2008. ,
BRAFE600-associated senescence-like cell cycle arrest of human naevi, Nature, vol.436, pp.720-724, 2005. ,
,
Dissection of RAS downstream pathways in melanomagenesis: a role for Ral in transformation, Oncogene, vol.29, pp.2449-2456, 2010. ,
The SYK tyrosine kinase: a crucial player in diverse biological functions, Nat Rev Immunol, vol.10, pp.387-402, 2010. ,
Epigenetic silencing of novel tumor suppressors in malignant melanoma, Cancer Res, vol.66, pp.11187-11193, 2006. ,
A novel role for high-mobility group a proteins in cellular senescence and heterochromatin formation, Cell, vol.126, pp.503-514, 2006. ,
Temozolomide-and fotemustine-induced apoptosis in human malignant melanoma cells: response related to MGMT, MMR, DSBs, and p53, Br J Cancer, vol.100, pp.322-333, 2009. ,
Melanoma biomarker expression in melanocytic tumor progression: a tissue microarray study, J Cutan Pathol, vol.37, 2010. ,
Cooperative interactions of PTEN deficiency and RAS activation in melanoma metastasis, Oncogene, 2010. ,
,
, Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium, Cancer Res, vol.59, pp.5002-5011
T-box genes in development: from hydra to humans, Int Rev Cytol, vol.207, pp.1-70, 2001. ,
Feedback between p21 and reactive oxygen production is necessary for cell senescence, Mol Syst Biol, vol.6, p.347, 2010. ,
,
BRAF mutations are sufficient to promote nevi formation and cooperate with p53 in the genesis of melanoma, 2005. ,
, Curr Biol, vol.15, pp.249-254
c-MYC: more than just a matter of life and death, Nat Rev Cancer, vol.2, pp.764-776, 2002. ,
Coexpression of NRASQ61R and BRAFV600E in human melanoma cells activates senescence and increases susceptibility to cell-mediated cytotoxicity, Cancer Res, vol.66, pp.6503-6511, 2006. ,
The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53, Cell, vol.92, pp.713-723, 1998. ,
BRAF and NRAS mutations in melanoma and melanocytic nevi, Melanoma Res, vol.16, pp.267-273, 2006. ,
Targeted disruption of the three Rb-related genes leads to loss of G(1) control and immortalization, Cancer Res Sage, vol.14, pp.3037-3050, 2000. ,
Dose-dependent oncogene-induced senescence in vivo and its evasion during mammary tumorigenesis, Nat Cell Biol, vol.9, pp.493-505, 2007. ,
Cyclin D1 is a candidate oncogene in cutaneous melanoma, Cancer Res, vol.62, pp.3200-3206, 2002. ,
A senescence program controlled by p53 and p16INK4a contributes to the outcome of cancer therapy, Cell, vol.109, pp.335-346, 2002. ,
Dynamic regulation of the human dopachrome tautomerase promoter by MITF, ER-alpha and chromatin remodelers during proliferation and senescence of human melanocytes, Pigment Cell Res, vol.18, pp.203-213, 2005. ,
The differential impact of p16(INK4a) or p19(ARF) deficiency on cell growth and tumorigenesis, Oncogene, vol.23, pp.379-385, 2004. ,
Increased cyclin D1 expression can mediate BRAF inhibitor resistance in BRAF V600E-mutated melanomas, Mol Cancer Ther, vol.7, pp.2876-2883, 2008. ,
Intron removal requires proofreading of U2AF/3' splice site recognition by DEK, Science, vol.312, pp.1961-1965, 2006. ,
Inactivation of the apoptosis effector Apaf-1 in malignant melanoma, Nature, vol.409, pp.207-211, 2001. ,
Apoptosis and melanoma chemoresistance, Oncogene, vol.22, pp.3138-3151, 2003. ,
Wide spectrum of tumors in knock-in mice carrying a Cdk4 protein insensitive to INK4 inhibitors, Embo J, vol.20, pp.6637-6647, 2001. ,
Prevalence of p16 and CDK4 germline mutations in 48 melanoma-prone families in France. The French Familial Melanoma Study Group, Hum Mol Genet, vol.7, pp.209-216, 1998. ,
Transient expression of human telomerase extends the life span of normal human fibroblasts, Biochem Biophys Res Commun, vol.273, pp.1095-1098, 2000. ,
Essential role of Microphthalmia transcription factor for DNA replication, mitosis and genomic stability in melanoma, Oncogene, 2010. ,
URL : https://hal.archives-ouvertes.fr/inserm-02530755
,
p16/cyclin-dependent kinase inhibitor 2A deficiency in human melanocyte senescence, apoptosis, and immortalization: possible implications for melanoma progression, J Natl Cancer Inst, vol.95, pp.723-732, 2003. ,
p16(Ink4a) in melanocyte senescence and differentiation, J Natl Cancer Inst, vol.94, pp.446-454, 2002. ,
The DEK protein--an abundant and ubiquitous constituent of mammalian chromatin, Gene, vol.343, pp.1-9, 2004. ,
Hypermethylation of Syk gene in promoter region associated with oncogenesis and metastasis of gastric carcinoma, World J Gastroenterol, vol.10, pp.1815-1818, 2004. ,
,
, Oncogenic BRAF regulates melanoma proliferation through the lineage specific factor MITF, PLoS One, vol.3, 2734.
Multiple binding sites in the growth factor receptor Xmrk mediate binding to p59fyn, GRB2 and Shc, Eur J Biochem, vol.260, pp.275-283, 1999. ,
Role of HDAC1 in senescence, aging, and cancer, Exp Gerontol, vol.45, pp.279-285, 2010. ,
Apoptosis inhibition by the human DEK oncoprotein involves interference with p53 functions, Mol Cell Biol, vol.26, pp.7506-7519, 2006. ,
The human DEK proto-oncogene is a senescence inhibitor and an upregulated target of high-risk human papillomavirus E7, J Virol, vol.79, pp.14309-14317, 2005. ,
HDAC family: What are the cancer relevant targets?, Cancer Lett, vol.277, pp.8-21, 2009. ,
, , 2007.
, Cellular senescence is an important mechanism of tumor regression upon c-Myc inactivation, Proc Natl Acad Sci U S A, vol.104, pp.13028-13033
DEK overexpression in uterine cervical cancers, Pathol Int, vol.58, pp.378-382, 2008. ,
Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas, Nature, vol.445, pp.656-660, 2007. ,
TBX3 is overexpressed in breast cancer and represses p14 ARF by interacting with histone deacetylases, Cancer Res, vol.68, pp.693-699, 2008. ,
Reduction of UVinduced cell death in the human senescent fibroblasts, Mol Cells, vol.10, pp.415-422, 2000. ,
Genetic analysis of Pten and Ink4a/Arf interactions in the suppression of tumorigenesis in mice, Proc Natl Acad Sci U S A, vol.99, pp.1455-1460, 2002. ,
Regulation of the human AP-endonuclease (APE1/Ref-1) expression by the tumor suppressor p53 in response to DNA damage, Nucleic Acids Res, vol.36, pp.1555-1566, 2008. ,
PI(3)king apart PTEN's role in cancer, Clin Cancer Res, vol.16, pp.4325-4330, 2010. ,
ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways, Cell, vol.92, pp.725-734, 1998. ,
Activation of PI3K/Akt and MAPK pathways regulates Myc-mediated transcription by phosphorylating and promoting the degradation of Mad1, Proc Natl Acad Sci U S A, vol.105, pp.6584-6589, 2008. ,
A genomic screen identifies TYRO3 as a MITF regulator in melanoma, Proc Natl Acad Sci U S A, vol.106, pp.17025-17030, 2009. ,
,
, , 2008.
Germline mutations in the p16INK4a binding domain of CDK4 in familial melanoma, Nat Genet, vol.12, pp.97-99, 1996. ,
The Syk tyrosine kinase localizes to the centrosomes and negatively affects mitotic progression, Cancer Res, vol.65, pp.10872-10880, 2005. ,